Table 2

- Clinical characteristics and laboratory results of the control and both patients’ cohorts (non-intensive and intensive care unit [ICU]-admitted) Covid-19 patients.

Characteristics	Controls (n=250)	Non-intensive COVID-19 cases (n=660)	ICU-admitted COVID-19 patients (n=41)	P-value (Kruskal Wallis)	P -value (between non-intensive and ICU)
Gender, n (%)
Male	138 (55.2) 112	295 (44.7) 365	22 (53.66)	0.013^*	0.12
Female	(44.8)	(55.3)	19 (46.34)	0.013^*	0.12
Age, years	48 (44.58-48.13)	35 (34.6-37.26)	45 (36.51-52.47)	<0.0001^*	0.0062^*
Red blood cell count x10⁶/L	5.08 (5.02-5.11)	4.72 (4.63-4.76)	4.6 (4.27-4.8)	<0.0001^*	0.37
Hemoglobin: g/dL	14 (13.65-14.06)	13.6 (13.01-14.25)	13.2 (12.09-13.35)	0.0012^*	0.067
Mean corpuscular fL	90.35 (88.74-90.8)	86.4 (84.9-86.34)	86.3 (83.35-88.14)	<0.0001^*	0.91
Mean corpuscular hemoglobin pg	29.55 (29.28-29.69)	28.8 (27.93-28.51)	28.6 (27.58-28.94)	<0.0001^*	0.63
Mean corpuscular hemoglobinconcentration g/dL	33 (32.91-33.14)	33 (32.62-33.06)	32.8 (32.54-33.22)	0.72	0.5
Platelet count x10³/μl	309.5 (297.5-320.7)	230 (238.9-258.3)	249 (245.5-309.9)	<0.0001^*	0.046^*
White blood cell count x10³/μl	7.2 (6.92-7.37)	5.37 (5.9-6.58)	6.96 (6.96-10.29)	<0.0001^*	0.0008^*
Neutrophil count x10³/μl	4.4 (4.28-4.64)	3.39 (3.92-4.56)	4.6 (4.47-7.57)	<0.0001^*	0.0043^*
Neutrophil percentage	58 (56.03-58.6)	66.1 (62.82-65.98)	76.05 (68.12-78.53)	<0.0001^*	0.0005^*
Lymphocyte count x10³/μl	2.1 (1.95-2.1)	1.2 (1.25-1.46)	1 (0.92-1.63)	<0.0001^*	0.05
Lymphocyte percentage	30.45 (29.8-31.31)	23.05 (23.3-26.13)	14.2 (13.29-21.34)	<0.0001^*	0.0007^*
Monocyte count x10³/μl	0.6 (0.61-0.69)	0.32 (0.31-0.62)	0.38 (0.37-0.62)	<0.0001^*	0.17
Neutrophil-to-lymphocyte ratio	2.18 (2.3-2.6)	2.85 (3.89-4.9)	5.5 (5.87-11.66)	<0.0001^*	0.0014^*

Laboratory results are stated asmedian values with 95% confidence intervals between brackets, unless stated otherwise.
↵* Statistical significance